References
- FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
- PaseroCSpeiserDEDerreLOliveDThe HVEM network: new directions in targeting novel costimulatory/co-inhibitory molecules for cancer therapyCurr Opin Pharmacol201212447848522445654
- TopalianSLHodiFSBrahmerJRSafety, activity, and immune correlates of anti-PD-1 antibody in cancerN Engl J Med2012366262443245422658127
- TopalianSLDrakeCGPardollDMImmune checkpoint blockade: a common denominator approach to cancer therapyCancer Cell201527445046125858804
- MurphyTLMurphyKMSlow down and survive: enigmatic immunoregulation by BTLA and HVEMAnnu Rev Immunol20102838941120307212
- HaymakerCLWuRCRitthipichaiKBTLA marks a less-differentiated tumor-infiltrating lymphocyte subset in melanoma with enhanced survival propertiesOncoimmunology201548e101424626405566
- InoueTShoMYasudaSHVEM expression contributes to tumor progression and prognosis in human colorectal cancerAnticancer Res20153531361136725750286
- ZhangTYeLHanLHeQZhuJKnockdown of HVEM, a lymphocyte regulator gene, in ovarian cancer cells increases sensitivity to activated T cellsOncol Res201624318919627458100
- MigitaKShoMShimadaKSignificant involvement of herpesvirus entry mediator in human esophageal squamous cell carcinomaCancer2014120680881724249528
- LiDFuZChenSHVEM gene polymorphisms are associated with sporadic breast cancer in Chinese womenPLoS One201388e7104023976978
- del RioMLLucasCLBuhlerLRayatGRodriguez-BarbosaJIHVEM/LIGHT/BTLA/CD160 cosignaling pathways as targets for immune regulationJ Leukoc Biol201087222323520007250
- SedyJRGavrieliMPotterKGB and T lymphocyte attenuator regulates T-cell activation through interaction with herpesvirus entry mediatorNat Immunol200561909815568026
- GonzalezLCLoyetKMCalemine-FenauxJA coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediatorProc Natl Acad Sci U S A200510241116112115647361
- PaseroCOliveDInterfering with coinhibitory molecules: BTLA/HVEM as new targets to enhance anti-tumor immunityImmunol Lett20131511–2717523439006
- ShuiJWKronenbergMHVEM: an unusual TNF receptor family member important for mucosal innate immune responses to microbesGut Microbes20134214615123333859
- EdgeSBComptonCCThe American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNMAnn Surg Oncol20101761471147420180029
- FengXYWenXZTanXJEctopic expression of B and T lymphocyte attenuator in gastric cancer: a potential independent prognostic factor in patients with gastric cancerMol Med Rep201511165866425334051
- KawazoeAKuwataTKubokiYClinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein–Barr virus status in a large cohort of gastric cancer patientsGastric Cancer Epub2016914
- LesokhinAMAnsellSMArmandPNivolumab in patients with relapsed or refractory hematologic malignancy: preliminary results of a Phase Ib studyJ Clin Oncol201634232698270427269947
- Abdel-RahmanOImmune checkpoints aberrations and gastric cancer; assessment of prognostic value and evaluation of therapeutic potentialsCrit Rev Oncol Hematol201697657126321371
- HeoSKJuSAKimGYThe presence of high level soluble herpes virus entry mediator in sera of gastric cancer patientsExp Mol Med201244214915822113134
- M’HidiHThibultMLChetailleBHigh expression of the inhibitory receptor BTLA in T-follicular helper cells and in B-cell small lymphocytic lymphoma/chronic lymphocytic leukemiaAm J Clin Pathol2009132458959619762537
- LaunayEPangaultCBertrandPHigh rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosisLeukemia201226355956221941365
- Gertner-DardenneJFauriatCOrlanducciFThe co-receptor BTLA negatively regulates human Vgamma9Vdelta2 T-cell proliferation: a potential way of immune escape for lymphoma cellsBlood2013122692293123692853
- Cancer Genome Atlas Research NetworkComprehensive molecular characterization of gastric adenocarcinomaNature2014513751720220925079317
- KataokaKShiraishiYTakedaYAberrant PD-L1 expression through 3′-UTR disruption in multiple cancersNature2016534760740240627281199